Nanexa Ab Stock Fundamentals
| NANEXA Stock | 1.27 0.05 3.79% |
Nanexa AB fundamentals help investors to digest information that contributes to Nanexa AB's financial success or failures. It also enables traders to predict the movement of Nanexa Stock. The fundamental analysis module provides a way to measure Nanexa AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanexa AB stock.
Nanexa |
Nanexa AB Company Return On Equity Analysis
Nanexa AB's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nanexa AB Return On Equity | -0.39 |
Most of Nanexa AB's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanexa AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Nanexa AB has a Return On Equity of -0.3902. This is 98.37% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers-Specialty & Generic industry. The return on equity for all Sweden stocks is 25.87% higher than that of the company.
Nanexa AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanexa AB's current stock value. Our valuation model uses many indicators to compare Nanexa AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanexa AB competition to find correlations between indicators driving Nanexa AB's intrinsic value. More Info.Nanexa AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanexa AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanexa AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nanexa Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanexa AB's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nanexa AB could also be used in its relative valuation, which is a method of valuing Nanexa AB by comparing valuation metrics of similar companies.Nanexa AB is currently under evaluation in return on equity category among its peers.
Nanexa Fundamentals
| Return On Equity | -0.39 | |||
| Return On Asset | -0.2 | |||
| Profit Margin | (2.23) % | |||
| Operating Margin | (2.00) % | |||
| Current Valuation | 34.48 M | |||
| Shares Outstanding | 60.7 M | |||
| Shares Owned By Insiders | 40.75 % | |||
| Price To Book | 0.68 X | |||
| Price To Sales | 3.34 X | |||
| Revenue | 2.37 M | |||
| Gross Profit | 4.31 M | |||
| EBITDA | (28.35 M) | |||
| Net Income | (36 M) | |||
| Total Debt | 2.57 M | |||
| Book Value Per Share | 2.19 X | |||
| Cash Flow From Operations | (25.13 M) | |||
| Earnings Per Share | (0.98) X | |||
| Number Of Employees | 19 | |||
| Beta | 0.74 | |||
| Market Capitalization | 244 M | |||
| Total Asset | 165 M | |||
| Z Score | 56.4 | |||
| Net Asset | 165 M |
About Nanexa AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanexa AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanexa AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanexa AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Nanexa Stock
Nanexa AB financial ratios help investors to determine whether Nanexa Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanexa with respect to the benefits of owning Nanexa AB security.